Gvoke VialDx is expected to be available in the third quarter of 2025. The Food and Drug Administration (FDA) has approved Gvoke VialDx ™ (glucagon) for intravenous use as a diagnostic aid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback